Hepapar (Apotheca Company)
Welcome to the PulseAid listing for the Hepapar drug offered from Apotheca Company. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | Apotheca Company |
NON-PROPRIETARY NAME: | Carduus marianus, Chelidonium majus, Taraxacum officinale |
SUBSTANCE NAME: | SILYBUM MARIANUM SEED; CHELIDONIUM MAJUS; TARAXACUM OFFICINALE; CHENOPODIUM AMBROSIOIDES; PORK LIVER; LYCOPODIUM CLAVATUM SPORE; MERCURIUS SOLUBILIS; SODIUM SULFATE; STRYCHNOS NUX-VOMICA SEED; PHOSPHO |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | ORAL |
DOSAGE FORM: | LIQUID |
MARKETING CATEGORY NAME: | UNAPPROVED HOMEOPATHIC |
START MARKETING DATE: | 2010-05-21 |
END MARKETING DATE: | 0000-00-00 |
Hepapar HUMAN OTC DRUG Details:
Item Description | Hepapar from Apotheca Company |
LABELER NAME: | Apotheca Company |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 3; 3; 3; 6; 6; 12; 12; 12; 12; 12([hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL) |
START MARKETING DATE: | 2010-05-21 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 57520-0413_bf47ad4a-c1a8-4ff8-a1f7-5ff5308c5018 |
PRODUCT NDC: | 57520-0413 |
APPLICATION NUMBER: | |
Other SILYBUM MARIANUM SEED; CHELIDONIUM MAJUS; TARAXACUM OFFICINALE; CHENOPODIUM AMBROSIOIDES; PORK LIVER; LYCOPODIUM CLAVATUM SPORE; MERCURIUS SOLUBILIS; SODIUM SULFATE; STRYCHNOS NUX-VOMICA SEED; PHOSPHO Pharmaceutical Manufacturers / Labelers: